1,2) ATL is characterized by malignant lympho-proliferation of mature activated T cells, predominantly CD4-positive T cells. This proliferation develops after a long period of latency following HTLV-1 infection. It is currently estimated that there are about twenty million HTLV-1 carriers worldwide. Of these, around 5% are at risk for ATL onset, and it has been reported that the incidence of ATL has been increasing. Epidemiological studies have indicated strongly that an increased HTLV-1 virus load is an important factor in ATL onset, although the detailed mechanisms of ATL onset are unknown. Therefore, an ideal anti-ATL agent would have both a growth inhibitory effect on ATL cells and an inhibitory effect on transmission of HTLV-1-infected cells. As 2 O 3 show promising results in the treatment of patients with ATL in combination with interferon (IFN)-a. [3] [4] [5] [6] [7] [8] Although As 2 O 3 -induced apoptosis is thought to play a major role in its observed therapeutic growth inhibitory effects in treating ATL 9,10) the effects of As 2 O 3 on HTLV-1 infection/transmission have not been reported.
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HTLV-1 can be distinguished from all other retroviruses on the basis of the infection process: it is transmitted almost exclusively via cell-to-cell contact and cell-to-cell fusion (also termed syncytium formation), and the free viral particle is very poorly infectious.
11) The HTLV-1 envelope glycoprotein is synthesized as a 61-kDa precursor that is cleaved into cellsurface (gp46) and transmembrane (gp21) proteins 12, 13) and the gp46 product is thought to play an important role as the virus attachment protein. HTLV-1 can induce syncytium formation between infected cells and certain uninfected cell types 14, 15) but this process can be blocked by antibodies against the gp46 protein or against gp46-derived peptides. 16, 17) Thus, gp46 is a key protein for HTLV-1 transmission via syncytium formation, which is a critical process for HTLV-1 transmission via cell-to-cell contact.
In the present study, we reveal that HTLV-1-induced syncytium formation can be blocked by As 2 O 3 treatment. Western blot analysis indicated that gp46 was down-regulated by As 2 O 3 treatment. Our results suggest that As 2 O 3 can prevent the HTLV-1 transmission by reducing levels of gp46, in addition to its therapeutic effect on ATL by promoting apoptosis. These results suggested that As 2 O 3 may open new avenues for treating HTLV-1-related diseases, including ATL.
MATERIALS AND METHODS

Cell Culture
The HTLV-1-infected cell line MT-2 (a kind gift from Hayashibara Biochemical Laboratories, Inc.) was grown in RPMI-1640 (Wako Pure Chemical Industries, Ltd., Osaka, Japan) supplemented with 10% heat-inactivated fetal calf serum and 1% Antibiotic-Antimycotic Mix stock solution (Nacalai Tesque, Osaka, Japan) in a humidified atmosphere of 95% air/5% CO 2 , at 37°C. A HeLa cell line was maintained in minimum essential medium (MEM-a; Wako) supplemented with 10% heat-inactivated fetal calf serum and 1% Antibiotic-Antimycotic Mix stock solution.
Detection of Syncytium Formation HeLa cells were plated at 8.0ϫ10
4 cells per well onto 12-well plates (Corning, NY, U.S.A.) and incubated for 36 h. MT-2 cells were preincubated for 12 h with or without As 2 O 3 , following irradiation at 12000 rads. As 2 O 3 -treated and irradiated HTLV-1-infected cells were then added to HeLa cells seeded into a 12-well plate at a concentration of 8.0ϫ10
4 viable cells per well. After 24 h co-culture, MT-2 cells were removed by washing with pre-warmed culture medium, and 200 ml of Hoechst 33342 (Dojindo, Kumamoto, Japan; 20 mg/ml) and 40 ml of CFSE (Dojindo; 100 mg/ml) were added to stain the nuclei and cytoplasm, respectively. After fixing with 4% paraformaldehyde, cells were analyzed using an ImageXpress MICRO High Content Screening System (Molecular Devices, Sunnyvale, CA, U.S.A.) and a fluorescence micro- scope. Syncytia containing Ͼ5 nuclei per cell were counted in triplicate wells.
Western Blots to Detect gp46 MT-2 was solubilised in IP lysis buffer (25 mM Tris-HCl pH 7.4, 100 mM NaCl, 2 mM ethylenediaminetetraacetic acid (EDTA), 0.5% (w/v) Triton X-100, 0.1% (v/v) protease inhibitor cocktail (Sigma, St. Louis, MO, U.S.A.)). 2.5 mg of cell lysates were subjected to SDS-polyacrylamide gel electrophoresis and transferred to a PVDF membrane. The proteins were visualized by immunoblot analysis; primary and secondary antibodies were anti-HTLV-1 gp46 antibody (ZeptoMetrix, Buffalo, NY, U.S.A.; 1 : 5000 dilution) and peroxidase-conjugated antimouse IgG (HϩL-chain) (MBL; 1 : 10000 dilution), respectively. As a loading control, beta actin was detected using anti-beta actin antibody (GeneTex, San Antonio, TX, U.S.A.; 1 : 80000 dilution).
RESULTS AND DISCUSSION
The infectivity of free HTLV-1 tends to be very poor, and the virus appears to be transmitted most efficiently by the cell-to-cell route. HTLV-1 infection is dependent upon the viral envelope glycoprotein-catalyzed fusion of the viral and cellular membranes. 18) Like many other retroviruses, HTLV-1 can induce syncytium formation between infected cells and certain uninfected cell types. Thus, to determine whether As 2 O 3 -treatment inhibits HTLV-1 transmission, we first carried out a syncytium formation assay using As 2 O 3 -treated MT-2 cells and uninfected HeLa cells. As shown in Figs. 1A and B, a significant number of syncytia were observed when untreated MT-2 cells were co-cultured with HeLa cells. In contrast, this syncytium formation was significantly decreased when MT-2 cells were pre-treated with 10 mM As 2 O 3 . The number of syncytia per field was 100 in As 2 O 3 -untreated MT-2 cells, but only 10 syncytia were observed in 10 mM As 2 O 3 -treated cultures. We also assessed the viability of 10 mM As 2 O 3 -treated MT-2 cells by WST-8 assay, and results indicated that there were no significant cytotoxicities (data not shown). Collectively, these results suggested that As 2 O 3 had an inhibitory effect on syncytium formation mediated by HTLV-1 infected cell lines without inducing cytotoxicity.
It has been reported that the HTLV-1 envelope protein gp46 interacts with GLUT1, HSC70 and heparin sulfate. These interactions play an important role in HTLV-1 transmission via cell-to-cell contact between HTLV-1 infected cells. [19] [20] [21] [22] [23] [24] Therefore, we next performed Western blots using an anti-gp46 antibody to determine whether the expression level of gp46, a key protein involved in HTLV-1 transmission, was changed by As 2 O 3 treatment. The gp46 expression level was significantly decreased in the MT-2 cell lines by As 2 O 3 treatment, indicating that As 2 O 3 treatment suppressed gp46 production. The HTLV-1 envelope protein is synthesized as a precursor protein (gp62), which is subsequently cleaved to a surface protein (gp46) and a transmembrane protein (gp21). 12, 13) Gp62 is modified by glycosylation events, proteolytically cleaved and inserted into the host cell membrane during virus particle assembly and release. 25, 26) It has been reported that inhibition of glycosylation, which is regulated by molecular chaperones, prevents both gp62 cleavage and syncytium formation. 25, [27] [28] [29] Because As 2 O 3 treatment suppresses gp46 but not gp62 (Fig. 2) , we speculated that it might inactivate the chaperone machinery. To clarify these mechanisms, we are now carrying out a proteomic analysis of As 2 O 3 -treated MT-2 cells. Previous reports 25, [27] [28] [29] indicated that as one of the factors of down-regulation of gp46 by As 2 O 3 treatment was caused by oxidation of protein chaperones causing their dysfunction, leading to suppression of gp46 production. These findings contradict the observations of Andrews et al., who reported that Na arsenite shock results in an increase in syncytium formation and gp62 expression. As 2 O 3 reportedly exerts dose-dependent dual effects on APL. Therefore, the 8-fold difference in the arsenic ion concentration between their methods and our methods might influence the cellular responses.
In summary, we have demonstrated that As 2 O 3 can inhibit HTLV-1 mediated syncytium formation, and that this is prob- ably due to suppression of gp46 production. Although more detailed studies are necessary to elucidate the causes of the observed effect on HTLV-1 transmission, it appears that dysfunction of chaperone proteins might contribute to the inhibitory effect of As 2 O 3 treatment on syncytium formation. Thus, we indicated that As 2 O 3 could inhibit HTLV-1 transmission as well as induce apoptosis to ATL cells. Because As 2 O 3 have carcinogenesis, it is necessary for safety use of As 2 O 3 to study the syncytium inhibition effect at low concentration. But, we believe that this study provides pertinent information related to the targeted discovery of drugs to treat ATL.
